US2003157662A1PendingUtilityA1

Compositions and methods for recombinational cloning of nucleic acid molecules

Assignee: INVITROGEN CORPPriority: Nov 13, 1998Filed: Nov 13, 2002Published: Aug 21, 2003
Est. expiryNov 13, 2018(expired)· nominal 20-yr term from priority
C07K 14/245C12N 15/66C12N 15/10
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates generally to compositions and methods for enhancing recombinational cloning of nucleic acid molecules. In particular, the invention relates to compositions comprising one or more ribosomal proteins and one or more additional protein components required for recombinational cloning. More particularly, the invention relates to such compositions wherein the ribosomal proteins are one or more E. coli ribosomal proteins, still more particularly wherein the ribosomal proteins are selected from the group of E. coli ribosomal proteins consisting of S10, S14, S15, S16, S17, S18, S19, S20, S21, L20, L21, and L23 through L34, and most particularly S20, L27, and S15. The invention also relates to the use of these compositions in methods for recombinational cloning of nucleic acids, in vitro and in vivo, to provide chimeric DNA molecules that have particular characteristics and/or DNA segments. The invention also relates to isolated nucleic acid molecules produced by the methods of the invention, to vectors comprising such nucleic acid molecules, and to host cells comprising such nucleic acid molecules and vectors.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A composition for use in cloning or subcloning one or more desired nucleic acid molecules by recombinational cloning, comprising an effective amount of at least one ribosomal protein and an effective amount of at least one recombination protein.  
     
     
         2 . The composition of  claim 1 , wherein said ribosomal protein is a prokaryotic ribosomal protein.  
     
     
         3 . The composition of  claim 1 , wherein said ribosomal protein is an  Escherichia coli  ribosomal protein.  
     
     
         4 . The composition of  claim 1 , wherein said ribosomal protein is a basic ribosomal protein.  
     
     
         5 . The composition of  claim 1 , wherein said ribosomal protein has a molecular weight of less than about 14 kilodaltons.  
     
     
         6 . The composition of  claim 3 , wherein said  E. coli  ribosomal protein is selected from the group of  E. coli  ribosomal proteins consisting of S10, S14, S15, S16, S17, S18, S19, S20, S21, L21, L23, L24, L25, L27, L28, L29, L30, L31, L32, L33 and L34.  
     
     
         7 . The composition of  claim 3 , wherein said  E. coli  ribosomal protein is S20.  
     
     
         8 . The composition of  claim 3 , wherein said  E. coli  ribosomal protein is L27.  
     
     
         9 . The composition of  claim 3 , wherein said  E. coli  ribosomal protein is S15.  
     
     
         10 . The composition of  claim 1 , wherein said recombination protein is a prokaryotic recombination protein.  
     
     
         11 . The composition of  claim 1 , wherein said recombination protein is selected from the group consisting of Int, Cre, FLP, Xis, IHF and HU, and combinations thereof.  
     
     
         12 . The composition of  claim 1 , wherein said recombination protein is Int.  
     
     
         13 . The composition of  claim 1 , further comprising one or more nucleic acid molecules selected from the group consisting of one or more Insert Donor molecules, one or more Vector Donor molecules, one or more Cointegrate molecules, one or more Product molecules and one or more Byproduct molecules.  
     
     
         14 . A method for cloning or subcloning one or more desired nucleic acid molecules comprising 
 (a) forming a combination by combining in vitro or in vivo 
 (i) one or more Insert Donor molecules comprising one or more desired nucleic acid segments flanked by at least two recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 (ii) one or more Vector Donor molecules comprising at least two recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 (iii) an effective amount of at least one recombination protein; and  
 (iv) all effective amount of at least one ribosomal protein; and  
   (b) incubating said combination under conditions sufficient to transfer one or more of said desired segments into one or more of said Vector Donor molecules, thereby producing one or more desired Product nucleic acid molecules.    
     
     
         15 . The method of  claim 14 , further comprising: 
 (c) forming a combination by combining in vitro or in vivo 
 (i) one or more of said Product molecules comprising said desired segments flanked by two or more recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 (ii) one or more different Vector Donor molecules comprising two or more recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 (iii) an effective amount of at least one recombination protein; and  
 (iv) an effective amount of at least one ribosomal protein; and  
   (d) incubating said combination under conditions sufficient to transfer one or more of said desired segments into one or more different Vector Donor molecules, thereby producing one or more different Product molecules.    
     
     
         16 . The method of  claim 14 , wherein said ribosomal protein is a prokaryotic ribosomal protein.  
     
     
         17 . The method of  claim 15 , wherein said ribosomal protein is a prokaryotic ribosomal protein.  
     
     
         18 . The method of  claim 14 , further comprising incubating said different Product molecules with one or more different Vector Donor molecules under conditions sufficient to transfer one or more of said desired segments into said different Vector Donor molecules.  
     
     
         19 . A method for cloning or subcloning desired nucleic acid molecules comprising 
 a) forming a combination by combining in vitro or in vivo 
 i) one or more Insert Donor molecules comprising one or more nucleic acid segments flanked by two or more recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 ii) two or more different Vector Donor molecules comprising two or more recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 iii) an effective amount of at least one recombination protein; and  
 iv) an effective amount of at least one ribosomal protein; and  
   b) incubating said combination under conditions sufficient to transfer one or more of said desired segments into said different Vector Donor molecules, thereby producing two or more different Product molecules.    
     
     
         20 . The method of  claim 19 , wherein said ribosomal protein is a prokaryotic ribosomal protein.  
     
     
         21 . The method of  claim 14 , wherein said ribosomal protein is an  Escherichia coli  ribosomal protein.  
     
     
         22 . The method of  claim 14 , wherein said ribosomal protein is a basic ribosomal protein.  
     
     
         23 . The method of  claim 14 , wherein said ribosomal protein has a molecular weight of less than about 14 kilodaltons.  
     
     
         24 . The method of  claim 21 , wherein said  E. coli  ribosomal protein is selected from the group of  E. coli  ribosomal proteins consisting of S10, S14, S15, S16, S17, S18, S19, S20, S21, L21, L23, L24, L25, L27, L28, L29, L30, L31, L32, L33 and L34.  
     
     
         25 . The method of  claim 21 , wherein said ribosomal protein is S20.  
     
     
         26 . The method of  claim 21 , wherein said ribosomal protein is L27.  
     
     
         27 . The method of  claim 21 , wherein said ribosomal protein is S115.  
     
     
         28 . The method of  claim 19 , wherein said recombination protein is a prokaryotic recombination protein.  
     
     
         29 . The method of  claim 14 , wherein said recombination protein is selected from the group consisting of Int, Cre, FLP, Xis, IHF, and HU, and combinations thereof.  
     
     
         30 . The method of  claim 14 , wherein said recombination protein is Int.  
     
     
         31 . A method for recombinational cloning of one or more desired nucleic acid molecules comprising 
 (a) forming a mixture by mixing one or more of said desired nucleic acid molecules with one or more vectors and with the composition of  claim 1;  and    (b) incubating said mixture under conditions sufficient to transfer said one or more desired nucleic acid molecules into one or more of said vectors.    
     
     
         32 . The method of  claim 31 , wherein said desired nucleic acid molecules are derived from genomic DNA.  
     
     
         33 . The method of  claim 31 , wherein said desired nucleic acid molecules are derived from cDNA.  
     
     
         34 . The method of  claim 31 , wherein said desired nucleic acid molecules are produced by chemical synthesis.  
     
     
         35 . The method of  claim 31 , wherein said desired nucleic acid molecules are produced by amplification.  
     
     
         36 . The method of  claim 31 , wherein said vector is a prokaryotic or eukaryotic vector.  
     
     
         37 . The method of  claim 36 , wherein said eukaryotic vector propagates and/or replicates in yeast cells, plant cells, fish cells, eukaryotic cells, mammalian cells, and/or insect cells.  
     
     
         38 . The method of  claim 31 , wherein said prokaryotic vector propagates and/or replicates in bacteria of the genera Escherichia, Salmonella, Bacillus, Streptomyces or Pseudomonas.  
     
     
         39 . The method of  claim 38 , wherein said prokaryotic vector propagates and/or replicates in  E. coli.    
     
     
         40 . A method for enhancement of recombinational cloning, comprising contacting a nucleic acid molecule with one or more ribosomal proteins and with one or more recombination proteins.  
     
     
         41 . The method of  claim 40 , wherein said ribosomal protein is a prokaryotic ribosomal protein.  
     
     
         42 . The method of  claim 40 , wherein said ribosomal protein is an  Escherichia coli  ribosomal protein.  
     
     
         43 . The method of  claim 40 , wherein said ribosomal protein is a basic ribosomal protein.  
     
     
         44 . The method of  claim 40 , wherein said ribosomal protein has a molecular weight of less than about 14 kilodaltons.  
     
     
         45 . The method of  claim 42 , wherein said  E. coli  ribosomal protein is selected from the group of  E. coli  ribosomal proteins consisting of S10, S14, S15, S16,S17, S18, S19,S20, S21,L21, L23,L24,L25,L27, L28,L29, L30, L31, L32, L33 and L34.  
     
     
         46 . The method of  claim 42 , wherein said ribosomal protein is S20.  
     
     
         47 . The method of  claim 42 , wherein said ribosomal protein is L27.  
     
     
         48 . The method of  claim 42 , wherein said ribosomal protein is S15.  
     
     
         49 . The method of  claim 40 , wherein said recombination protein is a prokaryotic recombination protein.  
     
     
         50 . The method of  claim 40 , wherein said recombination protein is selected from the group consisting of Int, Cre, FLP, Xis, IHF, and HU, and combinations thereof.  
     
     
         51 . The method of  claim 40 , wherein said recombination protein is Int.  
     
     
         52 . A DNA molecule produced by the method of  claim 31 .  
     
     
         53 . The DNA molecule of  claim 52 , wherein said DNA molecule is an isolated DNA molecule.  
     
     
         54 . A host cell comprising the DNA molecule of  claim 52 .  
     
     
         55 . A kit for use in recombinational cloning of a nucleic acid molecule, said kit comprising at least one ribosomal protein and at least one recombination protein.  
     
     
         56 . The kit of  claim 55 , wherein said ribosomal protein is a prokaryotic ribosomal protein.  
     
     
         57 . The kit of  claim 55 , wherein said ribosomal protein is an  Escherichia coli  ribosomal protein.  
     
     
         58 . The kit of  claim 57 , wherein said  E. coli  ribosomal protein is selected from the group of  E. coli  ribosomal proteins consisting of S10, S14, S15. S16, S17, S18, S19, S20, S21, L21, L23, L24, L25, L27, L28, L29, L30, L31, L32, L33 and L34.  
     
     
         59 . The kit of  claim 57 , wherein said ribosomal protein is S20.  
     
     
         60 . The kit of  claim 57 , wherein said ribosomal protein is L27.  
     
     
         61 . The kit of  claim 57 , wherein said ribosomal protein is S15.  
     
     
         62 . The kit of  claim 55 , wherein said recombination protein is a prokaryotic recombination protein.  
     
     
         63 . The kit of  claim 55 , wherein said recombination protein is selected from the group consisting of Int, Cre, FLP, Xis, IHF, and HU.  
     
     
         64 . The kit of  claim 55 , wherein said recombination protein is Int.

Join the waitlist — get patent alerts

Track US2003157662A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.